Cargando…
P405: IN VITRO RESPONSE TO BCL-2 INHIBITION IN PEDIATRIC B PRECURSOR ALL WITH HIGH RISK CYTOGENETICS
Autores principales: | Gottardi, Francesca, Messelodi, Daria, D’amico, Domenico, Baccelli, Francesco, Leardini, Davide, Nicola Bertuccio, Salvatore, Masetti, Riccardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10429741/ http://dx.doi.org/10.1097/01.HS9.0000968528.60716.f3 |
Ejemplares similares
-
ERCC6L2-related disease: a novel entity of bone marrow failure disorder with high risk of clonal evolution
por: Baccelli, Francesco, et al.
Publicado: (2023) -
Role of CBL Mutations in Cancer and Non-Malignant Phenotype
por: Leardini, Davide, et al.
Publicado: (2022) -
Are Induced Pluripotent Stem Cells a Step towards Modeling Pediatric Leukemias?
por: Bertuccio, Salvatore Nicola, et al.
Publicado: (2022) -
Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants
por: Baccelli, Francesco, et al.
Publicado: (2022) -
Chemotherapy-free treatment for acute promyelocytic leukemia: the pediatric view of a revolutionary tale
por: Masetti, Riccardo, et al.
Publicado: (2023)